Justice Department Probes Drug Pricing Practices By Merck, Eli Lilly And Valeant

The drug makers received inquiries from regional U.S. Attorney's offices seeking information about how they calculate and report drug prices for the Medicaid rebate program. In a separate inquiry, federal prosecutors are investigating allegations of fraudulent Tricare claims by several compounding pharmacies.